Rare Diseases and Pipeline

Amryt’s Products are Targeting Multiple Orphan Diseases

Amryt’s Products are Targeting Multiple Orphan Diseases

*Approved in the EU, Norway and Iceland, January 2016.

Email Alerts

Subscribe to Our Newsletter:

Delivered by Investis – link to website (opens in a new window)